Value2021202220232024TTMSelling/general/admin expenses——13.68 M13.64 M10.95 MResearch & development——34.75 M14.18 M5.52 MOperating income-1.94 M-3.33 M-1.87 M72.98 M-151.36 MNon-Operating Income, Total10.14 M14.19 M4.13 M30.98 M-11.78 MInterest expense, net of interest capitalized—————Non-Operating Income, excl. Interest Expenses10.14 M14.19 M3.84 M30.89 M-12.04 MUnusual income/expense——289 K95 K266 KPretax income8.2 M10.86 M-1.87 M42.01 M-226.02 MEquity in earnings—————Taxes-389.81 K883.33 K00—Non-controlling/minority interest—————After tax other income/expense——3 000——Net income before discontinued operations8.2 M9.98 M-1.87 M42.01 M-226.02 MDiscontinued operations—————Net income8.2 M9.98 M-1.87 M42.01 M-226.02 MDilution adjustment02.49 M———Preferred dividends26.38 M2.49 M———Diluted net income available to common stockholders-18.18 M9.98 M-1.87 M42.01 M-226.02 MBasic earnings per share (Basic EPS)37.4420.88-27.3677.7414.14Diluted earnings per share (Diluted EPS)37.4426.04-27.3672.939.33Average basic shares outstanding434.81 K383.33 K1.93 M540.36 K27.25 MDiluted shares outstanding434.81 K383.33 K1.93 M575.94 K27.29 MEBITDA—————EBIT—————Cost of revenue—————Other cost of goods sold—————Depreciation & amortization (cash flow)——68 K97 K81 K
AEON Biopharma Inc Class A
Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology.